Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Jasper Therapeutics Inc shares valued at $19,104 were sold by Mahal Jeetinder Singh on Sep 12 ’24. At $21.23 per share, Mahal Jeetinder Singh sold 900 shares. The insider’s holdings dropped to 25,009 shares worth approximately $0.46 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Jeetinder Singh Mahal purchased 900 shares, netting a total of over 18,590 in proceeds.
Before that, Mahal Jeetinder Singh had sold 900 shares from its account. In a trade valued at $21,740, the Chief Operating Officer traded Jasper Therapeutics Inc shares for $24.16 each. Upon closing the transaction, the insider’s holdings decreased to 900 shares, worth approximately $0.46 million.
As published in their initiating research note from JMP Securities on September 09, 2024, Jasper Therapeutics Inc [JSPR] has been a Mkt outperform and the price target has been revised to $70. Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in early July. As of June 27, 2024, Stifel has initiated its “Buy” rating for JSPR. Earlier on May 06, 2024, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for JSPR stock.
Analyzing JSPR Stock Performance
During the last five days, there has been a drop of approximately -19.83%. Over the course of the year, Jasper Therapeutics Inc shares have jumped approximately 131.05%. Shares of the company reached a 52-week high of $31.01 on 04/01/24 and a 52-week low of $6.41 on 01/02/24. A 50-day SMA is recorded $19.71, while a 200-day SMA reached $19.47. Nevertheless, trading volume fell to 0.69 million shares from 0.34 million shares the previous day.
Support And Resistance Levels for Jasper Therapeutics Inc (JSPR)
According to the 24-hour chart, there is a support level at 15.96, which, if violated, would cause prices to drop to 13.69. In the upper region, resistance lies at 21.91. The next price resistance is at 25.59. RSI (Relative Strength Index) is 38.97 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.99, which suggests the price will decrease in the coming days. Percent R is at 87.73%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
